MedTrace Logo

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

NCT03437551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-02-28

No results posted yet for this study

Summary

This study is designed to evaluate the prevalence of different stages of diabetic retinopathy and diabetic macular edema among patients suffering from type 1 diabetes (DM1) for 5 to 25 years and have been treated with intensified insulin therapy aiming near-normal blood glucose levels for the whole duration of disease.

Prevalence of different stages of diabetic retinopathy and diabetic macular edema is assessed using the modified Airlie House classification and the Early Treatment Diabetic Retinopathy Study (ETDRS) retinopathy severity scheme. Results of this study will provide the basis for designing further studies as well as staging and screening guidelines for diabetic retinopathy/diabetic macular edema.

Conditions

  • Insulin-Dependent Diabetes Mellitus 1

Interventions

OTHER

cross-sectional observation

cross-sectional ophthalmic examination

Sponsors & Collaborators

  • University Hospital, Zürich

    collaborator OTHER

  • Vista Klinik

    lead OTHER

Principal Investigators

  • Christian Pruente, MD · Vista Klinik Binningen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03437551 on ClinicalTrials.gov